Physician profile
Michael Kralik
NPI 1982642450
$9,421.39
in general payments reported to CMS, 2019-2025
21 companies · $1,229 in 2025
The $1,229 reported for 2025 was more than what a typical Thoracic Surgery (Cardiothoracic Vascular Surgery) provider received nationally (typical 2025 total: $796).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,236 · 2020: $115 · 2021: $1,686 · 2022: $1,274 · 2023: $1,006 · 2024: $2,874 · 2025: $1,229.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,312 · Long Term Medical Supply Or Device Loan: $2,278 · Travel and Lodging: $520.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,311.63 |
| Long Term Medical Supply Or Device Loan | $2,277.78 |
| Travel and Lodging | $519.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Angiodynamics, INC. | $2,338.93 | 2024-2025 | Auryon Laser System 100-120 Vac, Auryon Laser System 100-120 Vac |
| Edwards Lifesciences Corporation | $2,273.61 | 2019-2022 | |
| Endologix LLC | $1,611.16 | 2022-2025 | Afx2 Bifurcated Endograft System, Alto Abdominal Stent Graft System |
| Medtronic, INC. | $1,509.73 | 2022-2023 | Venaseal, Endurant Iis, Micra |
| Atricure, INC. | $713.00 | 2021 | |
| Boston Scientific Corporation | $141.69 | 2022-2025 | Varithena Administration Pack, General - Vascular Intervention |
| Abiomed | $125.90 | 2022 | |
| Nuvasive, INC. | $125.01 | 2019-2020 | |
| W. L. Gore & Associates, INC. | $94.51 | 2022-2025 | Excluder Conformable Aaa Endoprosthesis With Active Control, Gore Viabahn Endoprosthesis, Gore Tag Thoracic Branch Endoprosthesis |
| Chiesi USA, INC. | $81.25 | 2021 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $80.61 | 2019-2020 | |
| Amarin Pharma, INC. | $61.75 | 2019-2020 | |
| Bard Peripheral Vascular, INC. | $52.35 | 2024-2025 | Rotarexs 6 F X 135 Cm |
| Abbott Laboratories | $40.45 | 2025 | Esprit |
| Bolton Medical INC | $39.82 | 2023 | Treo Abdominal Stent-Graft System |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $37.54 | 2019-2020 | |
| Lemaitre Vascular, INC. | $33.56 | 2025 | Artegraft Vascular Graft, Hydro Lemaitre Valvulotome |
| Imperative Care, INC | $19.24 | 2025 | Symphony Catheter |
| Astrazeneca Pharmaceuticals LP | $15.94 | 2019 | |
| Inari Medical, INC. | $13.58 | 2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Novo Nordisk INC | $11.76 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Kralik listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.